On this page
Lyfgenia
lovotibeglogene autotemcel
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Lyfgenia
Proper name
lovotibeglogene autotemcel
Licence type
351(a)
BLA number
125788
Applicant
Genetix Biotherapeutics Inc.
Center
CBER
Presentations
1
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 1.7-20x10^6CELL/ML | Suspension | Intravenous | Bag | Rx | December 8, 2023 |
Exclusivity
Source: Purple Book| Kind | Expires |
|---|---|
| Orphan exclusivity | December 8, 2030 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |